News
The NIH Technology Transfer Program was honored with its record 7th “Deal of Distinction Award” at the 2025 Licensing Executives Society Annual Meeting. This award was given to NIH and its licensee Bavarian Nordic for the deal that led to the new chikungunya virus vaccine Vimkunya ®. Vimkunya
In May, the National Center for Advancing Translational Sciences (NCATS) and the Office of Strategic Alliances (OSA) held a two-day workshop to bring together technology transfer leaders and innovators to discuss how to best qualify and quantify the impact of Technology Transfer on the stakeholders
Are you interested in completely changing the current way HIV infections are addressed? Don’t miss your chance to hear from NCI’s Dr. Genoveffa Franchini about the opportunity to license or collaborate on a new HIV vaccine with the potential to prevent HIV infection and treat HIV. Currently, the FDA
The NIH Technology Transfer Community has done incredible work this past year. If you know of work that is deserving of recognition and award, we highly encourage you to nominate it for an FLC Regional award!